https://www.thecatalystbrief.com/ Independent editorial intelligence platform serving biotech CEOs, investors, and strategic operators with signal, not noise. en-us Sun, 13 Sep 2026 19:03:14 GMT https://www.thecatalystbrief.com/article/powerful-medical-wins-de-novo-ekg-classification-opening-a-higher-evidence-ai-triage-route https://www.thecatalystbrief.com/article/powerful-medical-wins-de-novo-ekg-classification-opening-a-higher-evidence-ai-triage-route Medical Technology Sun, 13 Sep 2026 19:00:48 GMT https://www.thecatalystbrief.com/article/ge-healthcare-eyes-up-to-1-billion-sofie-biosciences-deal-expanding-imaging-chemicals-reach https://www.thecatalystbrief.com/article/ge-healthcare-eyes-up-to-1-billion-sofie-biosciences-deal-expanding-imaging-chemicals-reach Medical Technology Sun, 13 Sep 2026 13:00:54 GMT https://www.thecatalystbrief.com/article/novartis-stumble-cuts-shares-more-than-13-spilling-into-lpa-rivals https://www.thecatalystbrief.com/article/novartis-stumble-cuts-shares-more-than-13-spilling-into-lpa-rivals Biopharmaceutical Industry Sun, 13 Sep 2026 07:00:57 GMT https://www.thecatalystbrief.com/article/pharma-wins-eu-wastewater-cost-challenge-targeting-80-treatment-funding-rule https://www.thecatalystbrief.com/article/pharma-wins-eu-wastewater-cost-challenge-targeting-80-treatment-funding-rule Regulatory & Policy Sat, 12 Sep 2026 07:02:05 GMT https://www.thecatalystbrief.com/article/marty-makary-names-jared-seehafer-to-new-fda-ai-post-as-mikhail-and-davis-gain-permanent-roles https://www.thecatalystbrief.com/article/marty-makary-names-jared-seehafer-to-new-fda-ai-post-as-mikhail-and-davis-gain-permanent-roles Regulatory & Policy Sat, 12 Sep 2026 07:02:05 GMT https://www.thecatalystbrief.com/article/samsung-biologics-signs-262-million-manufacturing-deal-extending-commitments-through-2033 https://www.thecatalystbrief.com/article/samsung-biologics-signs-262-million-manufacturing-deal-extending-commitments-through-2033 Biopharmaceutical Industry Sat, 12 Sep 2026 01:01:10 GMT https://www.thecatalystbrief.com/article/u-s-officials-end-record-cyclospora-outbreak-with-origin-still-unresolved https://www.thecatalystbrief.com/article/u-s-officials-end-record-cyclospora-outbreak-with-origin-still-unresolved Regulatory & Policy Sat, 12 Sep 2026 01:01:10 GMT https://www.thecatalystbrief.com/article/exelixis-delays-zanzalintinib-tecentriq-fda-decision-to-march-2027-after-agency-requests-updated-data https://www.thecatalystbrief.com/article/exelixis-delays-zanzalintinib-tecentriq-fda-decision-to-march-2027-after-agency-requests-updated-data Regulatory & Policy Fri, 11 Sep 2026 19:01:40 GMT https://www.thecatalystbrief.com/article/medicaid-lets-states-use-medical-frailty-tiers-easing-some-work-requirement-documentation-pressure https://www.thecatalystbrief.com/article/medicaid-lets-states-use-medical-frailty-tiers-easing-some-work-requirement-documentation-pressure Regulatory & Policy Fri, 11 Sep 2026 19:01:40 GMT https://www.thecatalystbrief.com/article/american-diabetes-association-faces-boycott-extending-fallout-from-june-conference-removals https://www.thecatalystbrief.com/article/american-diabetes-association-faces-boycott-extending-fallout-from-june-conference-removals Regulatory & Policy Fri, 11 Sep 2026 13:01:17 GMT https://www.thecatalystbrief.com/article/trump-administration-promises-500-aca-refund-checks-for-nearly-1-million-enrollees-before-midterms https://www.thecatalystbrief.com/article/trump-administration-promises-500-aca-refund-checks-for-nearly-1-million-enrollees-before-midterms Regulatory & Policy Fri, 11 Sep 2026 13:01:17 GMT https://www.thecatalystbrief.com/article/novartis-faces-board-pressure-after-del-desiran-miss-and-pelacarsen-failure-testing-its-post-2030-plan https://www.thecatalystbrief.com/article/novartis-faces-board-pressure-after-del-desiran-miss-and-pelacarsen-failure-testing-its-post-2030-plan Biopharmaceutical Industry Fri, 11 Sep 2026 07:01:18 GMT https://www.thecatalystbrief.com/article/cancer-centers-report-ongoing-drug-shortages-across-the-u-s-with-trials-disrupted-at-most-sites https://www.thecatalystbrief.com/article/cancer-centers-report-ongoing-drug-shortages-across-the-u-s-with-trials-disrupted-at-most-sites Regulatory & Policy Fri, 11 Sep 2026 07:01:18 GMT https://www.thecatalystbrief.com/article/platinum-chemotherapy-in-childhood-adds-about-2200-liver-mutations-per-sample-study-finds https://www.thecatalystbrief.com/article/platinum-chemotherapy-in-childhood-adds-about-2200-liver-mutations-per-sample-study-finds Biotech Innovation Fri, 11 Sep 2026 01:01:14 GMT https://www.thecatalystbrief.com/article/frazier-life-sciences-raises-more-than-1-1-billion-for-public-biotech-fund-extending-a-2021-vehicle https://www.thecatalystbrief.com/article/frazier-life-sciences-raises-more-than-1-1-billion-for-public-biotech-fund-extending-a-2021-vehicle Healthcare Investment Fri, 11 Sep 2026 01:01:14 GMT https://www.thecatalystbrief.com/article/takeda-plans-andy-plump-exit-in-june-2027-after-r-d-reorganization-and-recent-fda-approvals https://www.thecatalystbrief.com/article/takeda-plans-andy-plump-exit-in-june-2027-after-r-d-reorganization-and-recent-fda-approvals Biopharmaceutical Industry Thu, 10 Sep 2026 19:01:33 GMT https://www.thecatalystbrief.com/article/biohaven-faces-fda-enrollment-hold-on-bhv-7000-days-after-sk-biopharmaceuticals-license-deal https://www.thecatalystbrief.com/article/biohaven-faces-fda-enrollment-hold-on-bhv-7000-days-after-sk-biopharmaceuticals-license-deal Regulatory & Policy Thu, 10 Sep 2026 19:01:33 GMT https://www.thecatalystbrief.com/article/trump-administration-backs-ai-for-rural-care-as-providers-question-near-term-savings https://www.thecatalystbrief.com/article/trump-administration-backs-ai-for-rural-care-as-providers-question-near-term-savings Regulatory & Policy Thu, 10 Sep 2026 13:01:45 GMT https://www.thecatalystbrief.com/article/stat-reports-roivant-phase-2-win-for-mosliciguat-highlighting-another-dealmaking-payoff https://www.thecatalystbrief.com/article/stat-reports-roivant-phase-2-win-for-mosliciguat-highlighting-another-dealmaking-payoff Biopharmaceutical Industry Thu, 10 Sep 2026 13:01:45 GMT https://www.thecatalystbrief.com/article/luma-closes-410-million-debut-fund-stretching-life-sciences-bets-across-15-years https://www.thecatalystbrief.com/article/luma-closes-410-million-debut-fund-stretching-life-sciences-bets-across-15-years Healthcare Investment Thu, 10 Sep 2026 07:01:20 GMT https://www.thecatalystbrief.com/article/encoded-raises-275-million-for-etx101-and-manufacturing-advancing-dravet-gene-therapy-push https://www.thecatalystbrief.com/article/encoded-raises-275-million-for-etx101-and-manufacturing-advancing-dravet-gene-therapy-push Healthcare Investment Thu, 10 Sep 2026 01:01:12 GMT https://www.thecatalystbrief.com/article/arpa-h-commits-62-7-million-to-heart-failure-ai-program-seeking-fda-authorized-care-bots https://www.thecatalystbrief.com/article/arpa-h-commits-62-7-million-to-heart-failure-ai-program-seeking-fda-authorized-care-bots Regulatory & Policy Thu, 10 Sep 2026 01:01:12 GMT https://www.thecatalystbrief.com/article/fda-makes-michael-davis-and-karim-mikhail-permanent-center-heads-as-commissioner-pick-awaits-senate https://www.thecatalystbrief.com/article/fda-makes-michael-davis-and-karim-mikhail-permanent-center-heads-as-commissioner-pick-awaits-senate Regulatory & Policy Wed, 09 Sep 2026 19:01:42 GMT https://www.thecatalystbrief.com/article/caspian-launches-with-50-million-and-lilly-backing-to-push-menin-inhibitor-into-diabetes https://www.thecatalystbrief.com/article/caspian-launches-with-50-million-and-lilly-backing-to-push-menin-inhibitor-into-diabetes Biotech Innovation Wed, 09 Sep 2026 19:01:42 GMT https://www.thecatalystbrief.com/article/solstice-raises-225-million-series-a-moving-porustobart-into-phase-2-in-mss-colon-cancer https://www.thecatalystbrief.com/article/solstice-raises-225-million-series-a-moving-porustobart-into-phase-2-in-mss-colon-cancer Healthcare Investment Wed, 09 Sep 2026 13:02:03 GMT https://www.thecatalystbrief.com/article/forus-secures-150-million-series-c-at-3-billion-valuation-expanding-ai-medication-access-network https://www.thecatalystbrief.com/article/forus-secures-150-million-series-c-at-3-billion-valuation-expanding-ai-medication-access-network AI in Drug Discovery Wed, 09 Sep 2026 13:02:03 GMT https://www.thecatalystbrief.com/article/biospace-reports-crossover-rounds-could-top-4-22-billion-extending-biotechs-ipo-reopening https://www.thecatalystbrief.com/article/biospace-reports-crossover-rounds-could-top-4-22-billion-extending-biotechs-ipo-reopening Healthcare Investment Wed, 09 Sep 2026 07:01:27 GMT https://www.thecatalystbrief.com/article/bristol-myers-says-arlo-cel-met-quintessential-endpoint-extending-its-bid-in-post-bcma-myeloma https://www.thecatalystbrief.com/article/bristol-myers-says-arlo-cel-met-quintessential-endpoint-extending-its-bid-in-post-bcma-myeloma Biopharmaceutical Industry Wed, 09 Sep 2026 01:01:19 GMT https://www.thecatalystbrief.com/article/moonwalk-raises-70m-for-mw101-advancing-adipose-targeting-rnai-obesity-program-toward-2027-clinic-entry https://www.thecatalystbrief.com/article/moonwalk-raises-70m-for-mw101-advancing-adipose-targeting-rnai-obesity-program-toward-2027-clinic-entry Healthcare Investment Wed, 09 Sep 2026 01:01:19 GMT https://www.thecatalystbrief.com/article/pharvaris-reports-83-percent-attack-reduction-in-chapter-3-as-fda-verdict-on-deucrictibants-other-formulation-awaits https://www.thecatalystbrief.com/article/pharvaris-reports-83-percent-attack-reduction-in-chapter-3-as-fda-verdict-on-deucrictibants-other-formulation-awaits Biotech Innovation Tue, 08 Sep 2026 19:01:20 GMT https://www.thecatalystbrief.com/article/spyre-adds-third-phase-2-ulcerative-colitis-win-with-spy003-completing-its-three-antibody-induction-set https://www.thecatalystbrief.com/article/spyre-adds-third-phase-2-ulcerative-colitis-win-with-spy003-completing-its-three-antibody-induction-set Biotech Innovation Tue, 08 Sep 2026 19:01:20 GMT https://www.thecatalystbrief.com/article/brainchild-bio-raises-116-million-series-a-funding-bcb-276-toward-a-75-patient-dipg-study https://www.thecatalystbrief.com/article/brainchild-bio-raises-116-million-series-a-funding-bcb-276-toward-a-75-patient-dipg-study Healthcare Investment Tue, 08 Sep 2026 13:01:56 GMT https://www.thecatalystbrief.com/article/astrazeneca-wins-etcamah-approval-in-esr1-mutant-breast-cancer-despite-a-6-3-adcomm-vote-against https://www.thecatalystbrief.com/article/astrazeneca-wins-etcamah-approval-in-esr1-mutant-breast-cancer-despite-a-6-3-adcomm-vote-against Regulatory & Policy Tue, 08 Sep 2026 13:01:56 GMT https://www.thecatalystbrief.com/article/frank-pallone-jr-presses-six-idr-entities-over-no-surprises-act-compliance-after-2-5-million-2025-disputes https://www.thecatalystbrief.com/article/frank-pallone-jr-presses-six-idr-entities-over-no-surprises-act-compliance-after-2-5-million-2025-disputes Regulatory & Policy Tue, 08 Sep 2026 01:01:33 GMT https://www.thecatalystbrief.com/article/novo-nordisk-scraps-hermes-and-athena-phase-3-trials-narrowing-ziltivekimab-to-artemis https://www.thecatalystbrief.com/article/novo-nordisk-scraps-hermes-and-athena-phase-3-trials-narrowing-ziltivekimab-to-artemis Biopharmaceutical Industry Mon, 07 Sep 2026 19:00:55 GMT https://www.thecatalystbrief.com/article/proteomic-clocks-show-lower-biological-age-across-six-models-in-rentosertib-phase-2a-trial-extending-aging-endpoints-into-ipf-drug-development https://www.thecatalystbrief.com/article/proteomic-clocks-show-lower-biological-age-across-six-models-in-rentosertib-phase-2a-trial-extending-aging-endpoints-into-ipf-drug-development Biotech Innovation Mon, 07 Sep 2026 13:01:08 GMT https://www.thecatalystbrief.com/article/adarx-files-for-ipo-to-fund-three-clinical-sirna-programs-extending-2026-biotech-listing-run https://www.thecatalystbrief.com/article/adarx-files-for-ipo-to-fund-three-clinical-sirna-programs-extending-2026-biotech-listing-run Healthcare Investment Mon, 07 Sep 2026 07:01:11 GMT https://www.thecatalystbrief.com/article/massbio-and-scbio-select-10-startups-for-drive-extending-early-stage-support-to-capital-starved-founders https://www.thecatalystbrief.com/article/massbio-and-scbio-select-10-startups-for-drive-extending-early-stage-support-to-capital-starved-founders Healthcare Investment Sun, 06 Sep 2026 07:00:48 GMT https://www.thecatalystbrief.com/article/tactical-athletes-get-new-cardiovascular-guidance-expanding-care-standards-across-4-million-workers https://www.thecatalystbrief.com/article/tactical-athletes-get-new-cardiovascular-guidance-expanding-care-standards-across-4-million-workers Regulatory & Policy Sat, 05 Sep 2026 19:01:03 GMT https://www.thecatalystbrief.com/article/novartis-reports-pelacarsen-phase-3-miss-in-8323-patients-leaving-lpa-field-open https://www.thecatalystbrief.com/article/novartis-reports-pelacarsen-phase-3-miss-in-8323-patients-leaving-lpa-field-open Biotech Innovation Sat, 05 Sep 2026 07:00:58 GMT https://www.thecatalystbrief.com/article/truist-says-biotech-rebound-reached-136-billion-in-deals-as-financing-and-fda-risks-ease https://www.thecatalystbrief.com/article/truist-says-biotech-rebound-reached-136-billion-in-deals-as-financing-and-fda-risks-ease Healthcare Investment Fri, 04 Sep 2026 19:01:21 GMT https://www.thecatalystbrief.com/article/menarini-signs-664-million-bofanglutide-deal-giving-gan-lee-a-39-country-european-route https://www.thecatalystbrief.com/article/menarini-signs-664-million-bofanglutide-deal-giving-gan-lee-a-39-country-european-route Biopharmaceutical Industry Fri, 04 Sep 2026 19:01:21 GMT https://www.thecatalystbrief.com/article/stat-reports-lindsay-clancy-case-highlights-fragmented-u-s-care-and-postpartum-coordination-gaps https://www.thecatalystbrief.com/article/stat-reports-lindsay-clancy-case-highlights-fragmented-u-s-care-and-postpartum-coordination-gaps Regulatory & Policy Fri, 04 Sep 2026 13:02:21 GMT https://www.thecatalystbrief.com/article/invivyd-names-marc-elia-ceo-ahead-of-vyd2311-phase-3-covid-readout https://www.thecatalystbrief.com/article/invivyd-names-marc-elia-ceo-ahead-of-vyd2311-phase-3-covid-readout Biopharmaceutical Industry Fri, 04 Sep 2026 13:02:21 GMT https://www.thecatalystbrief.com/article/egenesis-reports-two-pig-kidney-recipients-later-received-human-donor-organs-easing-a-key-xenotransplant-concern https://www.thecatalystbrief.com/article/egenesis-reports-two-pig-kidney-recipients-later-received-human-donor-organs-easing-a-key-xenotransplant-concern Biotech Innovation Fri, 04 Sep 2026 07:01:24 GMT https://www.thecatalystbrief.com/article/fda-opens-tempo-pilot-to-four-generative-ai-devices-creating-a-limited-early-market-path https://www.thecatalystbrief.com/article/fda-opens-tempo-pilot-to-four-generative-ai-devices-creating-a-limited-early-market-path Regulatory & Policy Fri, 04 Sep 2026 07:01:24 GMT https://www.thecatalystbrief.com/article/ionis-wins-fda-approval-for-zanvastro-in-alexander-disease-opening-its-first-independent-neurology-launch https://www.thecatalystbrief.com/article/ionis-wins-fda-approval-for-zanvastro-in-alexander-disease-opening-its-first-independent-neurology-launch Biopharmaceutical Industry Fri, 04 Sep 2026 01:01:05 GMT https://www.thecatalystbrief.com/article/pfizer-transfers-pf-08046031-to-medicus-in-up-to-1b-plus-deal-extending-seagen-asset-recycling https://www.thecatalystbrief.com/article/pfizer-transfers-pf-08046031-to-medicus-in-up-to-1b-plus-deal-extending-seagen-asset-recycling Biopharmaceutical Industry Thu, 03 Sep 2026 19:01:19 GMT https://www.thecatalystbrief.com/article/arpa-h-commits-up-to-125m-for-give-rna-manufacturing-network-backing-distributed-personalized-production https://www.thecatalystbrief.com/article/arpa-h-commits-up-to-125m-for-give-rna-manufacturing-network-backing-distributed-personalized-production Regulatory & Policy Thu, 03 Sep 2026 19:01:19 GMT https://www.thecatalystbrief.com/article/gsk-bets-up-to-1-295-billion-on-hutchmed-hmpl-a830-extending-its-asia-deal-push https://www.thecatalystbrief.com/article/gsk-bets-up-to-1-295-billion-on-hutchmed-hmpl-a830-extending-its-asia-deal-push Biopharmaceutical Industry Thu, 03 Sep 2026 13:01:22 GMT